Investigation of a MOSFET dosimetry system for midpoint dose verification in prostate 3D CRT/IMRT
The suitability of MOSFETs (Metal Oxide Semiconductor Field Effect Transistors) for use in in-vivo dosimetry for IMRT prostate treatment and patient setup errors has been investigated in this work. MOSFETs were placed on entrance and exit surfaces of a number of different phantoms (with varying complexities from homogeneous to anthropomorphic). Dose measurements were then used to calculate a midpoint dose, which was compared with an IC placed at the isocentre. The agreements found between the calculated (MOSFETs) and the measured midpoint dose (IC) was: 0.7 % for a prostate treatment verification and 3.5 % for an IMRT treatment. MOSFETs placed on entry and exit surfaces can detect patient setup offsets of 2 cm, but do not have the sensitivity to confidently detect offsets of 1 cm or smaller.
Key wordsin-vivo dosimetry MOSFET prostate treatment IMRT
Unable to display preview. Download preview PDF.
- 1.Varadhan, R., Miller, J., Garrity, B. and Weber, M.,In vivo prostate IMRT dosimetry with MOSFET detectors using brass buldup caps, Jnl. Appl. Clin. Med. Phys., 7(4), p. 22–32, 2006.Google Scholar
- 8.Noel, D. and Taylor R., Med. Phys., July 15(3): 254–307, 1994Google Scholar
- 9.International Commission on Radiation Units and Measurements (ICRU) Report 50:Prescribing, Recording and Reporting Photon Beam Therapy, 1987.Google Scholar